Oncosil Medical Ltd has released a press release.
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-68
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from OncoSil Medical
- Quarterly Activities/Appendix 4C Cash Flow Report
- Trading Halt
- OncoSil receives $1.84m R&D tax incentive
- OSPREY Analysis Shows Survival Benefit for OncoSil Patients
- Response to ASX Aware Letter
Later from OncoSil Medical
- Capital Raising Presentation
- CEO Remuneration Update
- Appendix 4D and Half Year Accounts
- Security Class Suspension from Quotation
- Security Class Reinstatement to Quotation - OSLOE
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical